PETV ihub Friday, June 13, 2014 11:10:53 PM
Post# of 149
Posted On: 06/14/2014 12:10:13 AM
PETV News Friday, June 13, 2014 11:10:53 PM $PETV
PetVivo Holdings, Inc. Letter to Shareholders
Marketwire - Mon Jun 09, 5:48AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV)
PetVivo Holdings, Inc. Featured in Minneapolis / St. Paul Business Journal Article
Marketwire - Thu Jun 05, 2:01AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is featured in an article titled "Med-tech-for-pets venture in deal to buy Gel-Del for at least $40M" in the Minneapolis / St. Paul Business Journal. Reporter Katharine Grayson interviewed PetVivo CEO John Lai regarding the recently announced signing of a binding term sheet for a merger with Gel-Del Technologies, Inc.
PetVivo Patent Allowance Initiates Analyst Report: Bio-Medical Devices for Pets
PR Newswire - Mon Jun 02, 6:00AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics.
PetVivo Holdings, Inc. and Gel-Del Technologies, Inc. Sign Binding Term Sheet to Merge
Marketwire - Mon Jun 02, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) announced today it has entered into a binding term sheet for a merger with Gel-Del Technologies, Inc. Under the agreed upon terms Gel-Del will merge with PetVivo Holdings, Inc. and upon resolution of certain conditions specified as terms, a definitive agreement will consummate the merger.
PetVivo Announces Issuance of Notice of Allowance for Patent Application Covering the Kush(TM) Treatment for Animal Lameness in Canada
Marketwire - Thu May 29, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to announce that the Canadian Intellectual Property Office has issued a notice of allowance for the biomaterial contained in the Company's osteoarthritis product, which goes by the product name Kush(TM). This Canadian patent is one of the patents the Company has licensed from Gel-Del Technologies, Inc.
PetVivo Announces Access to Video Interview on SNN Live From Growth Capital Expo 2014
Marketwire - Tue May 27, 6:16AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics today announced that an interview with John Lai, CEO of the company from the Growth Capital Expo is now available at:
PetVivo Holdings CEO John Lai Interviewed in CEOCFO Magazine
Marketwire - Wed May 21, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics announced that CEO Mr. John Lai provided a comprehensive, in-depth interview to CEOCFO Magazine.
Technologies Scan Corp Completes Name Change to PetVivo Holdings, Inc. And Will Trade Under A New Symbol PETV On April 29th 2014
eTeligis - Tue Apr 29, 5:30AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), is pleased to provide shareholders with an update of recent activity within the company.
PetVivo Holdings, Inc. Letter to Shareholders
Marketwire - Mon Jun 09, 5:48AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV)
PetVivo Holdings, Inc. Featured in Minneapolis / St. Paul Business Journal Article
Marketwire - Thu Jun 05, 2:01AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is featured in an article titled "Med-tech-for-pets venture in deal to buy Gel-Del for at least $40M" in the Minneapolis / St. Paul Business Journal. Reporter Katharine Grayson interviewed PetVivo CEO John Lai regarding the recently announced signing of a binding term sheet for a merger with Gel-Del Technologies, Inc.
PetVivo Patent Allowance Initiates Analyst Report: Bio-Medical Devices for Pets
PR Newswire - Mon Jun 02, 6:00AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics.
PetVivo Holdings, Inc. and Gel-Del Technologies, Inc. Sign Binding Term Sheet to Merge
Marketwire - Mon Jun 02, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) announced today it has entered into a binding term sheet for a merger with Gel-Del Technologies, Inc. Under the agreed upon terms Gel-Del will merge with PetVivo Holdings, Inc. and upon resolution of certain conditions specified as terms, a definitive agreement will consummate the merger.
PetVivo Announces Issuance of Notice of Allowance for Patent Application Covering the Kush(TM) Treatment for Animal Lameness in Canada
Marketwire - Thu May 29, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to announce that the Canadian Intellectual Property Office has issued a notice of allowance for the biomaterial contained in the Company's osteoarthritis product, which goes by the product name Kush(TM). This Canadian patent is one of the patents the Company has licensed from Gel-Del Technologies, Inc.
PetVivo Announces Access to Video Interview on SNN Live From Growth Capital Expo 2014
Marketwire - Tue May 27, 6:16AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics today announced that an interview with John Lai, CEO of the company from the Growth Capital Expo is now available at:
PetVivo Holdings CEO John Lai Interviewed in CEOCFO Magazine
Marketwire - Wed May 21, 5:45AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics announced that CEO Mr. John Lai provided a comprehensive, in-depth interview to CEOCFO Magazine.
Technologies Scan Corp Completes Name Change to PetVivo Holdings, Inc. And Will Trade Under A New Symbol PETV On April 29th 2014
eTeligis - Tue Apr 29, 5:30AM CDT
PetVivo Holdings, Inc. (OTCQB: PETV), is pleased to provide shareholders with an update of recent activity within the company.
(0)
(0)